These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34932116)

  • 1. A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration.
    Huang WC; Cheng F; Chen CC; Kuo PH; Wang YJ; Yin SC; Tu CM; Wu MH; Wang WY; Chen SE
    Transl Vis Sci Technol; 2021 Dec; 10(14):23. PubMed ID: 34932116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.
    Horita S; Watanabe M; Katagiri M; Nakamura H; Haniuda H; Nakazato T; Kagawa Y
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00545. PubMed ID: 31763044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical noninvasive retinal drug delivery of a tyrosine kinase inhibitor: 3% cediranib maleate cyclodextrin nanoparticle eye drops in the rabbit eye.
    Lorenzo-Soler L; Praphanwittaya P; Olafsdottir OB; Kristinsdottir IM; Asgrimsdottir GM; Loftsson T; Stefansson E
    Acta Ophthalmol; 2022 Nov; 100(7):788-796. PubMed ID: 35080812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical Delivery of Anti-VEGF Drugs to the Ocular Posterior Segment Using Cell-Penetrating Peptides.
    de Cogan F; Hill LJ; Lynch A; Morgan-Warren PJ; Lechner J; Berwick MR; Peacock AFA; Chen M; Scott RAH; Xu H; Logan A
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2578-2590. PubMed ID: 28494491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits.
    Kansara VS; Muya LW; Ciulla TA
    Transl Vis Sci Technol; 2021 Jun; 10(7):19. PubMed ID: 34128964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration.
    Sun C; Zhang S; Xu N; Liu K; Wei F; Zhang X; Zhang J; Gao S; Yu Y; Ding X
    Int J Nanomedicine; 2024; 19():1887-1908. PubMed ID: 38414529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of TAK-593 Ophthalmic Emulsion for the Treatment of Age-Related Macular Degeneration.
    Mori Y; Yamamoto A; Nakagawa A; Hikima T; Isowaki A
    Biol Pharm Bull; 2023 Jul; 46(7):921-928. PubMed ID: 37164692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular tissue distribution and pharmacokinetic study of a small 13kDa domain antibody after intravitreal, subconjuctival and eye drop administration in rabbits.
    Gough G; Szapacs M; Shah T; Clements P; Struble C; Wilson R
    Exp Eye Res; 2018 Feb; 167():14-17. PubMed ID: 29074387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Pharmacokinetic Evaluation of High Melanin Binder Levofloxacin in Rabbits Shows Potential of Topical Eye Drops for Posterior Segment Treatment.
    Bahrpeyma S; Jakubiak P; Alvarez-Sánchez R; Caruso A; Leuthardt M; Senn C; Del Amo EM; Urtti A
    Invest Ophthalmol Vis Sci; 2024 Oct; 65(12):14. PubMed ID: 39382881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.
    Eyetech Study Group
    Retina; 2002 Apr; 22(2):143-52. PubMed ID: 11927845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
    Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
    Santonocito M; Zappulla C; Viola S; La Rosa LR; Solfato E; Abbate I; Tarallo V; Apicella I; Platania CBM; Maugeri G; D'Agata V; Bucolo C; De Falco S; Mazzone MG; Giuliano F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting retinal and choroid neovascularization using the small molecule inhibitor carboxyamidotriazole.
    Afzal A; Caballero S; Palii SS; Jurczyk S; Pardue M; Geroski D; Edelhauser H; Hochhaus G; Kim M; Franklin A; Shapiro G; Grant MB
    Brain Res Bull; 2010 Feb; 81(2-3):320-6. PubMed ID: 19679174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders.
    Obasanmi G; Nesbit MA; Cobice D; Mackay L; McGimpsey S; Wappett M; Cranston AN; Moore TCB
    Ophthalmol Sci; 2022 Jun; 2(2):100150. PubMed ID: 36249680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration.
    Yi Y; Pyun SH; Kim CY; Yun G; Kang E; Heo S; Ullah I; Lee SK
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
    Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
    Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.
    Dejneka NS; Wan S; Bond OS; Kornbrust DJ; Reich SJ
    Mol Vis; 2008 May; 14():997-1005. PubMed ID: 18523657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.